x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

tHEORetically Speaking

HealthEconomics.com

Insights, observations, and executive interviews that discuss data and evidence to guide value-based decisions in health care. For more, visit our blog: https://healtheconomics.com/theoretically-speaking/

science life sciences

All Episodes

4:06

Weekly News Roundup - Pharma Pilots, Legal Battles,...

tHEORetically Speaking ·

2025/08/08

This week's tHEORetically Speaking News Roundup covers the U.S. Department of Health and Human Services' new 340B rebate model pilot, a lawsuit against Novo Nordisk over misleading sales projections for Ozempic and Wegovy, and the GAO's findings on illegal NIH grant cuts by the Trump administration. We also delve into Merck's $10 billion acquisition of Verona Pharma and AstraZeneca's precision strategy in lung cancer treatment. Tune in for a concise recap of these pivotal industry updat...

en-us

4:33

Weekly News Roundup - Vaccine Triumphs, Revolutionary...

tHEORetically Speaking ·

2025/08/01

This week's tHEORetically Speaking News Roundup covers Moderna's strides toward COVID-19 vaccine approval in Europe, Eli Lilly's promising trial results for Jaypirca in leukemia treatment, and J&J's innovative CAR-T therapy ad campaign. We also explore the Trump administration's new health data sharing initiative and a groundbreaking platform predicting antibiotic resistance. Tune in for this concise recap of these pivotal industry updates!

en-us

28:32

tHEORetically Speaking: Meeting the Resource...

tHEORetically Speaking ·

2025/07/28

In this episode of Theoretically Speaking, Paige McGarry interviews David W. Miller, CEO of Genesis Research Group, discussing the unique challenges faced by biotech companies in evidence generation, market access, and stakeholder engagement. David W. Miller discusses how Genesis Research Group addresses these challenges, including the importance of demonstrating value early in development, the role of real-world evidence in supporting biotechs, and how to navigate uncertainty in the biotech ...

en-us

22:16

INsights & OUTcomes with Matt McLoughlin

tHEORetically Speaking ·

2025/06/10

This episode features Matt McLoughlin, Senior Vice President of Compliance and Categories at Scientist.com. With 25 years in pharma R&D and Procurement, Matt has enhanced outsourcing for biopharma companies, focusing on speed, efficiency, and compliance. His expertise in regulated industries extends to RWE, HEOR, and Market Access, transforming access to external services to boost innovation while cutting costs and project timelines. To stay connected with us, visit our LinkedIn page and...

en-us

24:42

INsights & OUTcomes with Catherine Bacon

tHEORetically Speaking ·

2025/05/20

Welcome to INsights & OUTcomes, the newest podcast on tHEORetically Speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisions. This episode features Catherine Bacon, founder of FingerPost Consulting in Manchester. She has more than 15 years of experience in market access, predominantly as a consultant. Driven by a passion for addressing the challenges of high-cost, innovative ...

en-us

32:11

INsights & OUTcomes with Vernon Schabert

tHEORetically Speaking ·

2025/04/28

Welcome to INsights & OUTcomes, the newest podcast on tHEORetically Speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisions. This episode features Dr. Vernon Schabert, Founder of Epilogix. Vernon is an internationally-recognized health economist and pharmacoepidemiologist and has nearly 30 years of HEOR, RWD, and RWE industry experience. To stay connected with us, visit our...

en-us

19:02

INsights & OUTcomes with Rosa Willock

tHEORetically Speaking ·

2025/03/31

Welcome to INsights & OUTcomes, the newest podcast on tHEORetically Speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisions.This episode features Rosa Willock, a Senior Consultant at Decisive Consulting. She leads the RWE function at Decisive Consulting, which includes helping clients to identify and address gaps in their evidence packages, and more recently, helping them to plan

en-us

30:49

INsights & OUTcomes with Chris O'Neill

tHEORetically Speaking ·

2025/03/10

Welcome to INsights & OUTcomes, the newest podcast on tHEORetically speaking from HealthEconomics.com, where we sit down with the leading professionals in HEOR, RWE, and market access, the experts shaping the future of healthcare decisions. This episode features Chris O'Neill, founder and CEO of Bosun MA. He has has over 20 years’ experience developing and delivering value and Market Access solutions for Pharma clients at a global and regional level. BOSUN MA has over 20 years of expertis...

en-us

1:18

INsights & OUTcomes - COMING SOON to tHEORetically...

tHEORetically Speaking ·

2025/02/24

Join us for INsights & OUTcomes where we sit down with the leading professionals in HEOR, RWE & RWD, and Market Access, the experts shaping the future of healthcare decisions. We'll dive into their careers, their passions, and the biggest trends in health economics today. We break down the numbers, challenge assumptions, and uncover what really drives healthcare decision making. Subscribe now!

en-us

23:03

tHEORetically speaking: Making Real-World Data...

tHEORetically Speaking ·

2024/11/07

This episode of tHEORetically Speaking features Jeffrey Brown, PhD and Matvey Palchuk, MD, MS, FAMIA of TriNetX, who discuss the rise of RWD and its role in revolutionizing healthcare research, and how the TriNetX team approaches data quality to ensure research-ready RWD.With increasing use of real-world data (RWD) throughout the drug development cycle — from initial discovery through to market approval and post-market monitoring — comes increasing scrutiny about the quality of the data. To w...

en-us

12:54

tHEORetically speaking: Between Two Scientists: Care...

tHEORetically Speaking ·

2024/09/24

This episode of tHEORetically Speaking is the fourth podcast in Panalgo’s ‘Between Two Scientists’, featuring host Meg Richards, PhD, MPH, who sits down with Panalgo’s VP of Medical Affairs, Dr. Mark Friedman, to discuss balancing the health needs of a pregnant woman and her developing baby, and how RWD can help.Have a listen to the third ‘Between Two Scientists’ podcast, where Norstella’s General Manager of RWD, Ted Search, highlighted the challenges of incorporating new types of unstructure...

en-us

14:41

tHEORetically speaking: How AI-Powered Phenotyping...

tHEORetically Speaking ·

2024/04/25

en-us

13:07

tHEORetically speaking: EU HTA Joint Clinical...

tHEORetically Speaking ·

2024/03/14

en-us

8:11

tHEORetically speaking: Clinical Outcomes Assessments...

tHEORetically Speaking ·

2024/03/14

en-us

5:18

tHEORetically speaking: Cell & Gene Therapies

tHEORetically Speaking ·

2024/03/14

en-us

15:10

tHEORetically speaking: Patient-Centered Real-World...

tHEORetically Speaking ·

2024/03/13

en-us

4:26

tHEORetically speaking: Real-World Evidence...

tHEORetically Speaking ·

2024/03/11

en-us

22:09

tHEORetically speaking: Clinical Outcome Assessment...

tHEORetically Speaking ·

2024/03/11

en-us

7:51

tHEORetically speaking: Between Two Scientists - New...

tHEORetically Speaking ·

2024/03/04

en-us

22:39

tHEORetically speaking: Total System Value™ - A...

tHEORetically Speaking ·

2024/01/08

en-us

69 results

Similar Podcasts

Classic Radio Science Fiction

solgoodmedia.com

Mission to Mars

Inception Point Ai

The 365 Days of Astronomy

365DaysOfAstronomy.org

Creek Devil

william Jevning

UFO Chronicles Podcast

Nik Hunter